Studies on cationic ocular emulsions containing bipartitioned oil droplets to codeliver cyclosporin A and etodolac

References

• Craig JP, Nichols KK, Akpek EK, Barbara CO, Dua HS, Joo CK. TFOS DEWS II – relazione su definizione e classificazione. Ocul. Surf. 30, 276–283 (2017).
   Google Scholar
• Han H, Li S, Xu M et al. Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives. Adv. Drug Deliv. Rev. 196, 114770 (2023).
   PubMed Web of Science ®Google Scholar
• Lallemand F, Schmitt M, Bourges JL, Gurny R, Benita S, Garrigue JS. Cyclosporine A delivery to the eye: a comprehensive review of academic and industrial efforts. Eur. J. Pharm. Biopharm. 117, 114–128 (2017).
   Web of Science ®Google Scholar
• Kang Q, Liu J, Zhao Y et al. Transdermal delivery system of nanostructured lipid carriers loaded with celastrol and indomethacin: optimization, characterization and efficacy evaluation for rheumatoid arthritis. Artif. Cells Nanomed. Biotechnol. 46, 585–597 (2018).
   PubMed Web of Science ®Google Scholar
• Teixeira H, Dubernet C, Rosilio V et al. New bicompartmental structures are observed when stearylamine is mixed with triglyceride emulsions. Pharma. Res. 17, 1329–1332 (2000).
   Google Scholar
• Raju RR, Kosmella S, Friberg SE, Koetz J. Pickering Janus emulsions and polyelectrolyte complex-stabilized Janus gels. Colloids Surf. A Physicochem. Eng. Asp. 533, 241–248 (2017).
   Web of Science ®Google Scholar
• Leonardi GR, Perrechil FA, Silveira LP, Brunca HO, Friberg SE. Silicone/vegetable oil Janus emulsion: topological stability versus interfacial tensions and relative oil volumes. J. Colloid Interface Sci. 449, 31–37 (2015).
   PubMed Web of Science ®Google Scholar
• Puri D, Khatik GL, Shunmugaperumal T. Studies on olive- and silicone-oils-based Janus macroemulsions containing ginger to manage primary dysmenorrheal pain. Mater. Sci. Eng. C Mater. Biol. Appl. 100, 276–285 (2019).
   PubMed Web of Science ®Google Scholar
• Pawde DM, Puppala ER, Rajdev B et al. From co-delivery to synergistic anti-inflammatory effect: studies on chitosan-stabilized Janus emulsions having chloroquine phosphate and flavopiridol in complete Freund's adjuvant induced arthritis rat model. Int. J. Biol. Macromol. 258, 128776 (2024).
   PubMed Web of Science ®Google Scholar
• Czogalla A. Oral cyclosporine A – the current picture of its liposomal and other delivery systems. Cell. Mol. Biol. Lett. 14(1), 139–152 (2009).
   PubMed Web of Science ®Google Scholar
• Di Tommaso C, Bourges JL, Valamanesh F, Trubitsyn G, Torriglia A, Jeanny JC. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. Eur. J. Pharm. Biopharm. 81(2), 257–264 (2012).
   PubMed Web of Science ®Google Scholar
• Rahman SNR, Pawde DM, Katari O, Hmingthansanga V, Shunmugaperumal T. Systematic optimization, in vitro drug release, and preliminary nonclinical toxicity assessment of nonphospholipid-based topical ophthalmic emulsions containing 0.05 or 0.1% w/w cyclosporin A for dry-eye syndrome management. AAPS PharmSciTech 21(2), 1–15 (2020).
   Web of Science ®Google Scholar
• Pflugfelder SC. Anti-inflammatory therapy for dry eye. Am. J. Ophthalmol. 137(2), 337–342 (2004).
   PubMed Web of Science ®Google Scholar
• Shah KP, Gumbhir-Shah K. Etodolac. In: Analytical Profiles of Drug Substances and Excipients. Brittain HG ( Ed.). Academic Press Inc., FL, USA, 105–147 (2002).
   Google Scholar
• Giuliano EA. Nonsteroidal anti-inflammatory drugs in veterinary ophthalmology. Vet. Clin. North Am. Small Anim. Pract. 34(3), 707–723 (2004).
   PubMed Web of Science ®Google Scholar
• Rahman SNR, Katari O, Pawde DM et al. Application of design of experiments® approach-driven artificial intelligence and machine learning for systematic optimization of reverse phase high-performance liquid chromatography method to analyze simultaneously two drugs (cyclosporin A and etodolac) in solution, human plasma, nanocapsules, and emulsions. AAPS PharmSciTech 22, 1–22 (2021).
   Web of Science ®Google Scholar
• Weiss SL, Kramer WG. Ocular distribution of cyclosporine following topical administration of OTX-101 in New Zealand white rabbits. J. Ocul. Pharmacol. Ther. 35(7), 395–402 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang A, Sun R, Ran M, Deng Y, Ge Y, Zhu Y. A novel eyes topical drug delivery system: CsA-LNC for the treatment of DED. Pharm. Res. 37(7), 1–14 (2020).
   Web of Science ®Google Scholar
• Binkhathlan Z, Alomrani AH, Hoxha O, Ali R, Kalam MA, Alshamsan A. Development and characterization of pegylated fatty acid-block-poly (ϵ-caprolactone) novel block copolymers and their self-assembled nanostructures for ocular delivery of cyclosporine A. Polymers 14(9), 1635 (2022).
   PubMed Web of Science ®Google Scholar
• De Miranda Silva C, Rocha A, Tozatto E, da Silva LM, Donadi A, Lanchote VL. Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics. J. Pharm. Biomed. Anal. 120, 120–126 (2016).
   PubMed Web of Science ®Google Scholar
• Rahman SNR, Goswami A, Sree A, Jala A, Borkar RM, Shunmugaperumal T. Dual delivery of cyclosporin A and etodolac using polymeric nanocapsules in a rabbit eye model: ocular biodistribution and pharmacokinetic study. J. Ocul. Pharmacol. Ther. 38(10), 734–744 (2022).
   PubMed Web of Science ®Google Scholar
• Yu Y, Chen D, Li Y, Yang W, Tu J, Shen Y. Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies. Drug Deliv. 25(1), 888–899 (2018).
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu J, Zhang X, Zhang R, Huang Y, Wu C. In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery. AAPS PharmSciTech 11(2), 610–620 (2010).
   PubMed Web of Science ®Google Scholar
• Shunmugaperumal T, Kaur V. In vitro anti-inflammatory and antimicrobial activities of azithromycin after loaded in chitosan- and tween 20-based oil-in-water macroemulsion for acne management. AAPS PharmSciTech 17(3), 700–709 (2016).
   PubMed Web of Science ®Google Scholar
• Rahman SNR. Characterization and safety assessment of oil-in-water nanosized emulsions. In: Oil-in-Water Nanosized Emulsions for Drug Delivery and Targeting. Shunmugaperumal T ( Ed.). John Wiley and Sons Inc., NJ, USA, 69–168 (2020).
   Google Scholar
• EMA. ICH Topic Q 1 A (R2). Stability Testing of New Drug Substances and Products. London, UK (2003). ( Accessed 23 February 2022). www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substances-products-step-5_en.pdf
   Google Scholar
• Rahman SNR, Agarwal N, Goswami A et al. Studies on spray dried topical ophthalmic emulsions containing cyclosporin A (0.05% w/w): systematic optimization, in vitro preclinical toxicity and in vivo assessments. Drug Deliv. Trans. Res. 2, 1–21 (2023).
   Google Scholar
• Álvarez-Álvarez L, Barral L, Bouza R, Farrag Y, Otero-Espinar F, Feijóo-Bandín S. Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: preparation, characterization and evaluation of ophthalmic toxicity. Int. J. Pharm. 568, 118519 (2019).
   PubMedGoogle Scholar
• Raval N, Khunt D, Misra M. Microemulsion-based delivery of triamcinolone acetonide to posterior segment of eye using chitosan and butter oil as permeation enhancer: an in vitro and in vivo investigation. J. Microencapsul. 35(1), 62–77 (2018).
   PubMed Web of Science ®Google Scholar
• Zhao L, Au JLS, Wientjes MG. Comparison of methods for evaluating drug–drug interaction. Front. Biosci. 2, 241 (2010).
   Google Scholar
• Kovshova T, Mantrov S, Boiko S, Malinovskaya J. Co-delivery of paclitaxel and etoposide prodrug by human serum albumin and PLGA nanoparticles: synergistic cytotoxicity in brain tumour cells. J. Microencapsul. 40(4), 246–262 (2023).
   PubMed Web of Science ®Google Scholar
• Chou TC. The combination index (CI <1) as the definition of synergism and of synergy claims. Synergy 7, 49–50 (2018).
   Google Scholar
• Nguyen TBT, Li S, Deratani A. Reverse micelles prepared from amphiphilic polylactide-b-poly (ethylene glycol) block copolymers for controlled release of hydrophilic drugs. Int. J. Pharm. 495(1), 154–161 (2015).
   PubMed Web of Science ®Google Scholar
• Peng F, Ke Y, Lu S, Zhao Y, Hu X, Deng Q. Anion amphiphilic random copolymers and their performance as stabilizers for O/W nanoemulsions. RSC Adv. 9(26), 14692–14700 (2019).
   PubMed Web of Science ®Google Scholar
• Vinardell MP, Mitjans M. The chorioallantoic membrane test as a model to predict the potential human eye irritation induced by commonly used laboratory solvents. Toxicol. In Vitro 20(6), 1066–1070 (2006).
   PubMed Web of Science ®Google Scholar
• Balls M, Botham PA, Bruner LH, Spielmann H. The EC/HO international validation study on alternatives to the Draize eye irritation test. Toxicol. In Vitro 9(6), 871–929 (1995).
   PubMed Web of Science ®Google Scholar
• Ahmed I, Gokhale RD, Shah MV, Patton TF. Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. J. Pharm. Sci. 76(8), 583–586 (1987).
   PubMed Web of Science ®Google Scholar
• Ghate D, Edelhauser HF. Ocular drug delivery. Expert Opin. Drug Deliv. 3(2), 275–287 (2006).
   PubMedGoogle Scholar
• Mandal A, Gote V, Pal D, Ogundele A, Mitra AK. Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa®) for dry eye disease. Pharm. Res. 36(2), 1–21 (2019).
   Web of Science ®Google Scholar
• Dong Y, Hengst L, Hunt R et al. Understanding drug distribution and release in ophthalmic emulsions through quantitative evaluation of formulation-associated variables. J. Control. Rel. 313, 96–105 (2019).
   PubMed Web of Science ®Google Scholar